These outcomes extend previous studies in which lipid-free apoA-IV reduced inflammation in a mouse model of colitis, inhibited histamine release from basophils in patients with allergic rhinitis and reduced TNF-α secretion from human monocytes following stimulation with lipopolysaccharide (20, 23, 41). This evidence concerns the gene TNF and colitis.